找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biotechnology in India - Reworking A Strategy; George John,Amulya K. Panda Book 2024 The Editor(s) (if applicable) and The Author(s), unde

[復(fù)制鏈接]
樓主: hypothyroidism
11#
發(fā)表于 2025-3-23 12:59:47 | 只看該作者
Marine Biotechnology in India: Status and Unfolding Opportunitiese centrepiece where different disciplines are converging to generate food and wealth..The phenomenal potential of the non-food sector of marine biotechnology unfolds through the promise of new drugs and bioactive compounds. Enzymes from various types of extremophilic marine organisms can lead to ind
12#
發(fā)表于 2025-3-23 15:31:12 | 只看該作者
Unveiling Fundamentals and Research Opportunities of mRNA Technologyse platforms, manufacturing intricacies, and inherent advantages. Initially conceptualized within the framework of the central dogma of molecular biology in the 1950s–1960s, mRNA serves as an intermediary for genetic information translation into functional proteins. This chapter delves into the vari
13#
發(fā)表于 2025-3-23 21:58:52 | 只看該作者
Vaccine Research and Development in India for COVID-19 and Influenzathe world’s largest vaccine manufacturers and has successfully vaccinated a large fraction of its population to protect against COVID-19 disease caused by the sarbecovirus, SARS-CoV-2. However, much of this was reliant on formulations developed elsewhere, and before vaccines could be widely deployed
14#
發(fā)表于 2025-3-24 02:05:24 | 只看該作者
Development of Genetically Engineered Vaccine and Post-Exposure Therapy Against Anthraxcal weapon, research and development of effective vaccines and post-exposure therapeutics has been crucial. Currently available anthrax vaccines such as Anthrax Vaccine Adsorbed (AVA) and Anthrax Vaccine Precipitate (AVP) are tightly regulated and not commercially available. FDA approved prophylacti
15#
發(fā)表于 2025-3-24 03:41:48 | 只看該作者
16#
發(fā)表于 2025-3-24 08:27:38 | 只看該作者
17#
發(fā)表于 2025-3-24 10:44:06 | 只看該作者
18#
發(fā)表于 2025-3-24 15:15:46 | 只看該作者
19#
發(fā)表于 2025-3-24 19:10:38 | 只看該作者
Catalysing and Accelerating a New Phase in Indian Biopharmactively through ‘reverse engineering’ skills. A similar success story lies behind biogenerics produced through the biotech route. These remarkable successes have laid a solid foundation for a cash-rich and confident pharmaceutical industry to successfully cater to the ever-growing need for affordabl
20#
發(fā)表于 2025-3-25 01:50:24 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 16:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
黄梅县| 同江市| 鲁山县| 永德县| 普兰县| 通城县| 宁海县| 鄂托克旗| 哈巴河县| 吉林市| 绥滨县| 富顺县| 新晃| 华坪县| 娄底市| 元阳县| 东乡族自治县| 信阳市| 大余县| 阜平县| 乐昌市| 蚌埠市| 辽阳县| 涞水县| 长泰县| 台中县| 新郑市| 育儿| 福州市| 永胜县| 高邑县| 德化县| 溆浦县| 桐梓县| 海阳市| 资兴市| 云龙县| 巴楚县| 龙州县| 英吉沙县| 都昌县|